Differential Expression of Alternatively Spliced c-erbB-2 mRNA in Primary Tumors, Lymph Node Metastases, and Bone Marrow Micrometastases from Breast Cancer Patients
- 18 June 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 247 (2), 319-323
- https://doi.org/10.1006/bbrc.1998.8779
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prognostic significance of HER-2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinomaCancer, 1997
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- The erbB oncogenes as prognostic markers in oral squamous cell carcinomasThe American Journal of Surgery, 1996
- A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptorNucleic Acids Research, 1996
- Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: Double-differential polymerase chain reaction (ddPCR) for clinical diagnosisGene, 1995
- c-erbB3 Gene Encodes Secreted as Well as Transmembrane Receptor Tyrosine KinaseBiochemical and Biophysical Research Communications, 1993
- A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells.Molecular and Cellular Biology, 1993
- C-terminal truncated forms of Met, the hepatocyte growth factor receptor.Molecular and Cellular Biology, 1991
- Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.Journal of Clinical Oncology, 1991
- c-erbB-2 expression in benign and malignant breast diseaseBritish Journal of Cancer, 1988